Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Filamon LTD
Ensem Therapeutics
Atavistik Bio, Inc
Eisai Inc.
PMV Pharmaceuticals, Inc
AstraZeneca
NiKang Therapeutics, Inc.
Kivu Bioscience Inc.
NeoImmuneTech
Alterome Therapeutics, Inc.
Hoffmann-La Roche
AstraZeneca
BeOne Medicines
Bayer
Genmab
Genmab
Convalife (Shanghai) Co., Ltd.
Eli Lilly and Company
ViroMissile, Inc.
Arcus Biosciences, Inc.
Terremoto Biosciences Inc.
Bristol-Myers Squibb
Genmab
Jazz Pharmaceuticals
Accent Therapeutics
AstraZeneca
Tizona Therapeutics, Inc
A2 Biotherapeutics Inc.
AstraZeneca
Clasp Therapeutics, Inc.
Normunity AccelCo, Inc.
Eli Lilly and Company
NiKang Therapeutics, Inc.
Poseida Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
Avacta Life Sciences Ltd
AstraZeneca
SystImmune Inc.
Daiichi Sankyo
Amgen
SN BioScience
Eli Lilly and Company
AstraZeneca
EXoPERT
Adela, Inc
Radiopharm Theranostics, Ltd
Second Life Therapeutics
Eli Lilly and Company